Dr. Heather Wakelee is a Professor of Medicine and Chief of the Division of Oncology at Stanford University, and Deputy Director of the Stanford Cancer Institute. Dr. Wakelee serves as the President of the International Association for the Study of Lung Cancer (IASLC); an Executive Committee member of ECOG-ACRIN, and she is a Fellow of the American Society of Clinical Oncology (FASCO). She is a graduate of Princeton University and Johns Hopkins University School of Medicine and completed her post-graduate training at Stanford University. As an experienced lung cancer investigator, Dr. Wakelee has authored or co-authored over 200 medical articles on lung cancer and thymic malignancies and is involved in dozens of clinical trials involving adjuvant therapy, immunotherapy, and anti-angiogenesis agents. Her research focuses on many specific lung cancer subtypes defined by specific mutations in EGFR, ALK, ROS1, RET, BRAF and others. Her translational efforts to date have involved collaborations with colleagues in medical oncology, thoracic radiation oncology, thoracic surgery, radiology, pulmonary medicine, and population sciences
Heather Wakelee, MD, FASCO
Professor of Medicine and Chief, Division of Oncology
Stanford University
Interim Medical Director, Stanford Cancer Center
Deputy Director, Stanford Cancer Institute
Executive Committee Member, ECOG-ACRIN
President, International Association for the Study of Lung Cancer (IASLC)
